M. Eileen Dolan
M. Eileen Dolan
Professor of Medicine, University of Chicago
Dirección de correo verificada de
Citado por
Citado por
Molecular mechanisms of resistance and toxicity associated with platinating agents
CA Rabik, ME Dolan
Cancer treatment reviews 33 (1), 9-23, 2007
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS
DL Nicolae, E Gamazon, W Zhang, S Duan, ME Dolan, NJ Cox
PLoS genetics 6 (4), e1000888, 2010
The gene ontology (GO) project in 2006
Gene Ontology Consortium
Nucleic acids research 34 (suppl_1), D322-D326, 2006
Human polymorphism at microRNAs and microRNA target sites
MA Saunders, H Liang, WH Li
Proceedings of the National Academy of Sciences 104 (9), 3300-3305, 2007
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase
AE Pegg, ME Dolan, RC Moschel
Progress in nucleic acid research and molecular biology 51, 167-223, 1995
Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against …
ME Dolan, RC Moschel, AE Pegg
Proceedings of the National Academy of Sciences 87 (14), 5368-5372, 1990
Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2
R Humerickhouse, K Lohrbach, L Li, WF Bosron, ME Dolan
Cancer research 60 (5), 1189-1192, 2000
AgBase: a functional genomics resource for agriculture
FM McCarthy, N Wang, GB Magee, B Nanduri, ML Lawrence, EB Camon, ...
BMC genomics 7, 1-13, 2006
Testicular cancer survivorship: research strategies and recommendations
LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ...
Journal of the national cancer institute 102 (15), 1114-1130, 2010
Mouse models of human AML accurately predict chemotherapy response
J Zuber, I Radtke, TS Pardee, Z Zhao, AR Rappaport, W Luo, ...
Genes & development 23 (7), 877-889, 2009
The pharmacogenetics research network: from SNP discovery to clinical drug response
KM Giacomini, CM Brett, RB Altman, NL Benowitz, ME Dolan, ...
Clinical Pharmacology & Therapeutics 81 (3), 328-345, 2007
Effect of O6-Benzylguanine Analogues on Sensitivity of Human Tumor Cells to the Cytotoxic Effects of Alkylating Agents
ME Dolan, RB Mitchell, C Mummert, RC Moschel, AE Pegg
Cancer research 51 (13), 3367-3372, 1991
Chemotherapy-induced peripheral neuropathy: Current status and progress
JR Brewer, G Morrison, ME Dolan, GF Fleming
Gynecologic oncology 140 (1), 176-183, 2016
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics
F Innocenti, DL Kroetz, E Schuetz, ME Dolan, J Ramírez, M Relling, ...
Journal of Clinical Oncology 27 (16), 2604, 2009
O6-benzylguanine and its role in chemotherapy.
ME Dolan, AE Pegg
Clinical cancer research: an official journal of the American Association …, 1997
Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia
B Diouf, KR Crews, G Lew, D Pei, C Cheng, J Bao, JJ Zheng, W Yang, ...
Jama 313 (8), 815-823, 2015
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
EE Vokes, MS Kies, DJ Haraf, K Stenson, M List, R Humerickhouse, ...
Journal of Clinical Oncology 18 (8), 1652-1661, 2000
SCAN: SNP and copy number annotation
ER Gamazon, W Zhang, A Konkashbaev, S Duan, EO Kistner, DL Nicolae, ...
Bioinformatics 26 (2), 259-262, 2010
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
J Bockhorn, R Dalton, C Nwachukwu, S Huang, A Prat, K Yee, YF Chang, ...
Nature communications 4 (1), 1393, 2013
The gene ontology knowledgebase in 2023
SA Aleksander, J Balhoff, S Carbon, JM Cherry, HJ Drabkin, D Ebert, ...
Genetics 224 (1), iyad031, 2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20